NEVVI Medicare utilization intelligence
or

← back

Provider profile

O'SHAUGHNESSY, JOYCE MD

Medical Oncology · NPI 1790727709 · DALLAS, TX

1
Groups
72
Codes · 2024
118,570
Disclosed services

O'SHAUGHNESSY, JOYCE is a Medical Oncology in DALLAS, TX, a member of 1 medical group, who billed 72 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

118,570
disclosed services
72
codes billed to Medicare Part B
Prior year · CY2023 111,460 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9263 Injection, oxaliplatin, 0.5 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9299 Injection, nivolumab, 1 mg
J9025 Injection, azacitidine, 1 mg
J0897 Injection, denosumab, 1 mg
J1930 Injection, lanreotide, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9073 Injection, cyclophosphamide (ingenus), 5 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J9171 Injection, docetaxel, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
Q5116 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
J9041 Injection, bortezomib, 0.1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
J0640 Injection, leucovorin calcium, per 50 mg
J9395 Injection, fulvestrant, 25 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J9190 Injection, fluorouracil, 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96375 Injection of additional new drug or substance into vein
J9206 Injection, irinotecan, 20 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
82378 Carcinoembryonic antigen (cea) protein level
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J9045 Injection, carboplatin, 50 mg
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
J3489 Injection, zoledronic acid, 1 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
71046 X-ray of chest, 2 views
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9000 Injection, doxorubicin hydrochloride, 10 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3475 Injection, magnesium sulfate, per 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
J9060 Injection, cisplatin, powder or solution, 10 mg
96372 Injection of drug or substance under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
J3490 Unclassified drugs
71260 Ct scan of chest with contrast
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
74177 Ct scan of abdomen and pelvis with contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96361 Infusion into a vein for hydration, each additional hour
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96411 Administration of additional new drug or substance into vein using push technique
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96377 Application of on-body injector for under skin injection
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
83540 Iron level
96409 Administration of chemotherapy into vein using push technique
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
71250 Ct scan of chest without contrast
96523 Irrigation of implanted venous access drug delivery device
84443 Blood test, thyroid stimulating hormone (tsh)
70491 Ct scan of soft tissue of neck with contrast
74176 Ct scan of abdomen and pelvis without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.